NO20002124D0 - Nye karboksylsyrederivater med amid-sidekjeder, deres fremstilling og anvendelse som endothelin-reseptorantagonister - Google Patents
Nye karboksylsyrederivater med amid-sidekjeder, deres fremstilling og anvendelse som endothelin-reseptorantagonisterInfo
- Publication number
- NO20002124D0 NO20002124D0 NO20002124A NO20002124A NO20002124D0 NO 20002124 D0 NO20002124 D0 NO 20002124D0 NO 20002124 A NO20002124 A NO 20002124A NO 20002124 A NO20002124 A NO 20002124A NO 20002124 D0 NO20002124 D0 NO 20002124D0
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- carboxylic acid
- side chains
- acid derivatives
- receptor antagonists
- Prior art date
Links
- 229940118365 Endothelin receptor antagonist Drugs 0.000 title 1
- 150000001408 amides Chemical group 0.000 title 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 title 1
- 239000002308 endothelin receptor antagonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19748238 | 1997-10-31 | ||
| DE19752904A DE19752904A1 (de) | 1997-10-31 | 1997-11-28 | Neue Carbonsäurederivate, die Amidseitenketten tragen, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten |
| DE1998109376 DE19809376A1 (de) | 1998-03-05 | 1998-03-05 | Neue Carbonsäurederivate, die Amidseitenketten tragen, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten |
| PCT/EP1998/006571 WO1999023078A2 (fr) | 1997-10-31 | 1998-10-16 | Nouveaux derives d'acide carboxylique, portant des chaines laterales amidees; leur mode de production et leur utilisation en tant qu'antagonistes recepteurs d'endotheline |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20002124L NO20002124L (no) | 2000-04-26 |
| NO20002124D0 true NO20002124D0 (no) | 2000-04-26 |
Family
ID=27217881
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20002124A NO20002124D0 (no) | 1997-10-31 | 2000-04-26 | Nye karboksylsyrederivater med amid-sidekjeder, deres fremstilling og anvendelse som endothelin-reseptorantagonister |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6509341B1 (fr) |
| EP (1) | EP1027338A2 (fr) |
| JP (1) | JP2001521927A (fr) |
| CN (1) | CN1278251A (fr) |
| AU (1) | AU2266199A (fr) |
| BG (1) | BG104396A (fr) |
| BR (1) | BR9814951A (fr) |
| CA (1) | CA2307770A1 (fr) |
| HR (1) | HRP980560A2 (fr) |
| HU (1) | HUP0100054A3 (fr) |
| ID (1) | ID24278A (fr) |
| IL (1) | IL135347A0 (fr) |
| NO (1) | NO20002124D0 (fr) |
| NZ (1) | NZ504316A (fr) |
| PL (1) | PL340871A1 (fr) |
| SK (1) | SK4592000A3 (fr) |
| TR (1) | TR200001182T2 (fr) |
| WO (1) | WO1999023078A2 (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19806438A1 (de) * | 1998-02-17 | 1999-08-19 | Basf Ag | Neue Carbonsäurederivate mit 5-substituiertem Pyrimidinring, ihre Herstellung und Verwendung |
| DE19933164A1 (de) * | 1999-07-20 | 2001-01-25 | Basf Ag | Neue Carbonsäurederivate mit 5,6 substituiertem Pyrimidinring, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten |
| JPWO2001085693A1 (ja) | 2000-05-11 | 2004-01-08 | 萬有製薬株式会社 | Ｎ−アシルテトラヒドロイソキノリン誘導体 |
| DE10025728A1 (de) * | 2000-05-25 | 2001-11-29 | Basf Ag | Neue Carbamate und Harnstoffe, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten |
| WO2002064573A1 (fr) * | 2001-02-14 | 2002-08-22 | Abbott Gmbh & Co. Kg | Nouveaux derives d'acide carboxylique contenant des triazines a substitution alkyle, leur production et leur utilisation en tant qu'antagonistes du recepteur d'endotheline |
| ATE327744T1 (de) | 2001-03-20 | 2006-06-15 | Sanol Arznei Schwarz Gmbh | Neue verwendung von peptidverbindungen bei der behandlung von nicht-neuropathischem entzündungsschmerz |
| EP1243263B1 (fr) | 2001-03-21 | 2002-11-27 | Schwarz Pharma Ag | Nouvelle utilisation d'une classe de composés peptidiques pour le traitement de l'allodynie ou d'autres types de douleurs chroniques ou fantômes |
| US8008351B2 (en) | 2004-04-16 | 2011-08-30 | Ucb Pharma Gmbh | Methods for prophylaxis or treatment of conditions associated with cortical spreading depression |
| EP1604656A1 (fr) | 2004-06-09 | 2005-12-14 | Schwarz Pharma Ag | Utilisation nouvelle de peptides pour le traitement de la sclérose amytrophique latérale (ALS) |
| DE602005021970D1 (de) | 2004-08-27 | 2010-08-05 | Ucb Pharma Gmbh | Verwendung von peptidverbindungen zur behandlung von schmerzen durch knochenkrebs, chemotherapie- und nucleosid-bedingten schmerzen |
| BRPI0709950A2 (pt) * | 2006-04-13 | 2011-08-02 | Actelion Pharmaceuticals Ltd | uso de bosentan na preparação de um medicamento para o tratamento de fibrose pulmonar idiopática em estágio precoce e uso de antagonista do receptor endotelin |
| PL2462990T3 (pl) | 2006-06-15 | 2014-05-30 | Ucb Pharma Gmbh | Kompozycja farmaceutyczna obejmująca lakozamid i lewetyracetam o synergistycznym działaniu przeciwdrgawkowym |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4313412A1 (de) | 1993-04-23 | 1994-10-27 | Basf Ag | 3-(Het)aryl-Carbonsäurederivate, Verfahren und Zwischenprodukte zu ihrer Herstellung |
| DE4313413A1 (de) * | 1993-04-23 | 1994-10-27 | Basf Ag | 3-(Het)aryloxy(thio)-Carbonsäurederivate, Verfahren und Zwischenprodukte zu ihrer Herstellung |
| DE4411225A1 (de) | 1994-03-31 | 1995-10-05 | Basf Ag | Verwendung von Carbonsäurederivaten als Arzneimittel |
| DE19533023B4 (de) * | 1994-10-14 | 2007-05-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
| DE19614534A1 (de) * | 1996-04-12 | 1997-10-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
-
1998
- 1998-10-16 SK SK459-2000A patent/SK4592000A3/sk unknown
- 1998-10-16 TR TR2000/01182T patent/TR200001182T2/xx unknown
- 1998-10-16 JP JP2000518953A patent/JP2001521927A/ja active Pending
- 1998-10-16 CN CN98810875A patent/CN1278251A/zh active Pending
- 1998-10-16 US US09/529,860 patent/US6509341B1/en not_active Expired - Fee Related
- 1998-10-16 WO PCT/EP1998/006571 patent/WO1999023078A2/fr not_active Ceased
- 1998-10-16 HU HU0100054A patent/HUP0100054A3/hu unknown
- 1998-10-16 EP EP98966230A patent/EP1027338A2/fr not_active Withdrawn
- 1998-10-16 CA CA002307770A patent/CA2307770A1/fr not_active Abandoned
- 1998-10-16 ID IDW20000816A patent/ID24278A/id unknown
- 1998-10-16 PL PL98340871A patent/PL340871A1/xx unknown
- 1998-10-16 IL IL13534798A patent/IL135347A0/xx unknown
- 1998-10-16 NZ NZ504316A patent/NZ504316A/xx unknown
- 1998-10-16 BR BR9814951-2A patent/BR9814951A/pt not_active IP Right Cessation
- 1998-10-16 AU AU22661/99A patent/AU2266199A/en not_active Abandoned
- 1998-10-26 HR HR19809376.4A patent/HRP980560A2/hr not_active Application Discontinuation
-
2000
- 2000-04-26 NO NO20002124A patent/NO20002124D0/no not_active Application Discontinuation
- 2000-05-02 BG BG104396A patent/BG104396A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK4592000A3 (en) | 2000-12-11 |
| BR9814951A (pt) | 2000-10-03 |
| EP1027338A2 (fr) | 2000-08-16 |
| NZ504316A (en) | 2002-12-20 |
| US6509341B1 (en) | 2003-01-21 |
| NO20002124L (no) | 2000-04-26 |
| IL135347A0 (en) | 2001-05-20 |
| WO1999023078A3 (fr) | 1999-09-10 |
| JP2001521927A (ja) | 2001-11-13 |
| HUP0100054A3 (en) | 2002-03-28 |
| HRP980560A2 (en) | 1999-08-31 |
| WO1999023078A2 (fr) | 1999-05-14 |
| CA2307770A1 (fr) | 1999-05-14 |
| HUP0100054A1 (hu) | 2002-02-28 |
| ID24278A (id) | 2000-07-13 |
| BG104396A (en) | 2001-02-28 |
| TR200001182T2 (tr) | 2000-11-21 |
| AU2266199A (en) | 1999-05-24 |
| PL340871A1 (en) | 2001-03-12 |
| CN1278251A (zh) | 2000-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1157005T3 (da) | 3-phenylpyridinderivater og anvendelsen deraf som NK-1-receptorantagonister | |
| DK1538160T3 (da) | Substituerede isochinolin-3-carboxylsyreamider, deres fremstilling og deres anvendelse som lægemiddel | |
| DK1394150T3 (da) | 4-phenylpyridinderivater og deres anvendelse som NK-1-receptorantagonister | |
| NO20015064L (no) | Karbaminsyre-derivater og deres anvendelse som metabotrope glutamat-reseptor-ligander | |
| NO20005266D0 (no) | Nye substituerte amider, deres fremstilling og anvendelse | |
| NO981522D0 (no) | Aminosyrederivater, deres fremstilling og anvendelse som endotelinantagonister | |
| DK1163239T3 (da) | Modificerede aminosyreamider som CGRP-antagonister | |
| NO991761D0 (no) | Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse | |
| NO991079D0 (no) | Azinyloksy-og fenoksy-diaryl-karboksylsyre-derivater, deres fremstilling og deres anvendelse som bladete ETA/ETB-endothelin-reseptor-antagonister | |
| NO996115D0 (no) | Azetidinylpropylpiperidin-derivater, intermediater og anvendelse som tachykinin-antagonister | |
| NO20002124D0 (no) | Nye karboksylsyrederivater med amid-sidekjeder, deres fremstilling og anvendelse som endothelin-reseptorantagonister | |
| NO20023146D0 (no) | Substituerte fenyl-piperazinderivater, deres fremstilling og anvendelse | |
| NO984713L (no) | Nye karboksylsyre-derivater, deres fremstilling og anvendelse | |
| NO992976L (no) | Heterocykliske karboksylsyre-derivater, fremstilling og anvendelse derav som endothelinreseptor-antagonister | |
| NO20014224L (no) | 4-heterocyklysulfonamidyl-6-metoksy-5-(2-metoksy-fenoksy)-2- pyridyl-pyrimidinderivater, fremstilling derav og anvendelse somendotelin reseptor antagonister | |
| NO996268D0 (no) | Nye <beta>-amino- og <beta>-azidokarboksylsyrederivater, fremstilling derav og anvendelse derav som endothelinreseptorantagonister | |
| NO20001077D0 (no) | Nye karboksylsyrederivater, deres fremstilling og anvendelse som blandete ETA/ETB-endothelin-reseptorantagonister | |
| NO20040426L (no) | Nye imidazolidinderivater og deres fremstilling og andvendelse som VLA-4-antagonister. | |
| NO20010622D0 (no) | Nye karboksylsyrederivater som bærer keto-sidekjeder, deres fremstilling og deres anvendelse som endotelinreseptor- antagonister | |
| NO20004075D0 (no) | Substituerte pyrimidin-2-yloksy-karboksylsyrederivater, fremstilling av disse og deres anvendelse som endotelin- antagonister | |
| NO20020254D0 (no) | Nye karboksylsyrederivater med 5,6-substituert pyrimidinring, fremstilling og anvendelse derav som endotelinreseptor-antagonister | |
| IL143451A0 (en) | NEW- β-AMIDE AND β-SULFONAMIDE CARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS | |
| ZA989923B (en) | Novel carboxylic acid derivatives with amide side chains, their preparation and use as endothelin receptor antagonists. | |
| DK1235809T3 (da) | Substituerede 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazociner og deres anvendelse som lægemidler | |
| NO20000324D0 (no) | Benzotia (oksa) diazolderivater og deres anvendelse som endotelinreseptorantagonister |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |